Naranjo VBT, León SMA, Iglesias RMB, Sainz PL

Language: Spanish
References: 15
Page: 1-11
PDF size: 510.32 Kb.

ABSTRACT

Introduction: ocular toxoplasmosis is the most frequent cause of posterior uveitis of known etiology in the world, mainly in children and young adults.
Objective: to determine the clinical-epidemiological characteristics of ocular toxoplasmosis in pediatric patients in Pinar del Río province in the period 2012-2018.
Methods: an analytical cross-sectional, observational study was conducted on 39 patients with ocular toxoplasmosis, who were treated at the Uveitis clinic of Abel Santamaría Cuadrado General Teaching Hospital between January 2012 and December 2018. The variables studied were: age, sex, risk factors, symptoms, clinical findings, complications and visual acuity.
Results: the disease was more frequent in patients between 15 and 18 years old (46,2 %). Risk conditions were poor quality of drinking water (100 %), and inadequate food handling (89,7%). There is association with a significance level of 10% (p=0,066) between symptoms and type of uveitis according to anatomical location. There was also association between CVMA with anatomical location (p=0,001), extent of the lesion (p=0,011) and to a lesser extent with anatomical classification (p=0,083). The presence of scar in macular area and vasculitis was evident in 33,3 % and 12,8% respectively.
Conclusions: the presence of poor hygienic conditions was frequent. Prevention and timely treatment are the best ways to reduce blindness due to toxoplasmosis in children.

REFERENCES

1. Intraocular Inflammation and Uveitis. USA American Academy of Ophthalmology; 2015. 9p.

2. Sánchez R, Sánchez L, Miranda A, Camejo L, Araujo L. La toxoplasmosis observada como un problema no resuelto. Rev Cubana de Investigaciones Biomédicas [Internet]. 2015 [citado 06/04/2017]; 35(3): [aprox. 2p.]. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002016000300006

3. Ambou Frutos I, Vilches Lescaille DC, Osorio Illas L. Toxoplasmosis ocular. En: Rio Torres M, Fernández Argones L, Hernández Silva JR, Ramos López M. Oftalmología. Diagnóstico y tratamiento. 2da ed. La Habana: Editorial Ciencias Médicas; 2018.

4. Bhikoo R, Damato EM, Guest S, Sims J. Primary Ocular Toxoplasmosis Presenting to Uveitis Services in a Non-endemic Setting. Korean J Ophthalmol [Internet]. 2019 Dec [citado 26/02/2020]; 33(6): 514-9. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/31833248

5. Yates WB, Chiong F, Zagora S, Post JJ, Wakefield D, McCluskey P. Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis. Asia Pac J Ophthalmol (Phila) [Internet]. 2019 Jul-Aug [citado 26/02/2020]; 8(4): 280-4. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/31369405

6. Gontijo da Silva M, Clare Vinaud M, Castro AM. Prevalence of toxoplasmosis in pregnant women and vertical transmission of Toxoplasma gondii in patients from basic units of health from Gurupi, Tocantins, Brazil. PLoS ONE [Internet]. 2015 [citado 06/04/2017]; 10(11): [aprox. 10p.]. Disponible en: Disponible en: https://doi.org/10.1371/journal.pone.0141700

7. Faciolince LA, López de Mesa C, de-la-Torre A. Toxoplasmosis ocular en Colombia: 10 años de aportes investigativos. Bogotá, Colombia. Rev. SCO [Internet]. 2018 Ene - Jun [citado 13/03/2018]; 51(1): 16-28. Disponible en: Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=7025785

8. Garweg JG. Ocular Toxoplasmosis: an Update. Klin Monbl Augenheilkd [Internet]. 2016 Apr [citado 26/02/2020]; 233(4): 534-9. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27116531

9. Martín García E, Chávarri García JJ, Rodríguez Vicente L, Jiménez Del Río B, Guallar Leza SM, Del Río Mayor JL. Management of the neovascular choroidal membrane secondary to ocular toxoplasmosis. Arch Soc Esp Oftalmol [Internet]. 2020 Feb [citado 26/02/2020]; 95(2): 90-3. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/31879139

10. Greigert V, Pfaff AW, Sauer A, Filisetti D, Candolfi E, Villard O. Biological Diagnosis of Ocular Toxoplasmosis: a Nine-Year Retrospective Observational Study. mSphere [Internet]. 2019 Sep-25 [citado 26/02/2020]; 4(5): e00636-19. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/31554726

11. Samudio M, Acosta ME, Castillo V, Guillén Y, Licitra G, Aria L, et al. Aspectos clínico-epidemiológicos de la toxoplasmosis en pacientes que consultan por problemas de visión. Rev Chilena Infectol [Internet]. 2015 [citado 06/04/2017]; 32(6): [aprox. 6p.]. Disponible en: Disponible en: http://www.scielo.cl/pdf/rci/v32n6/art07.pdf

12. Hasanreisoğlu M, Özdek Ş, Gülpınar İkiz GD, Aktaş Z, Atalay T. Effects of Congenital Ocular Toxoplasmosis on Peripheral Retinal Vascular Development in Premature Infants at Low Risk for Retinopathy of Prematurity. Turk J Ophthalmol [Internet]. 2019 Sep-3 [citado 26/02/2020]; 49(4): 230-4. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/31486615

13. Moghaddas E, Hosseini SM, Sharifi K, Rezai A, Soleimanpour S, Miri Moghaddam MM, et al. IgG Avidity Test for Ocular Toxoplasmosis Diagnosis at a Tertiary Center, Northeast of Iran. Iran J Immunol [Internet]. 2019 Sep [citado 26/02/2020]; 16(3): 258-64. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/31552834

14. Smith JR, Ashander LM, Ma Y, Rochet E, Furtado JM. Model Systems for Studying Mechanisms of Ocular Toxoplasmosis. Methods Mol Biol [Internet]. 2020 [citado 26/02/2020]; 2071: 297-321. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/31758460

15. Naranjo Valladares BT, López Torres M, Moreno Domínguez JC, Acosta Rodríguez F. La uveítis, comportamiento clínico epidemiológico en Pinar del Río. Rev. Ciencias Médicas [Internet]. 2015 [citado 08/04/2017]; 19(2): [aprox. 9 p.]. Disponible en: Disponible en: http://scielo.sld.cu/pdf/rpr/v19n2/rpr11215.pdf